InflaRx intends to develop izicopan in ANCA-associated vasculitis (AAV), with a secondary goal of establishing rapid proof of ...
Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...
MarketBeat on MSN
InflaRx investor update: Izicopan set to take center stage in AAV and renal disease pipeline
InflaRx (NASDAQ:IFRX) outlined plans to prioritize development of izicopan, an oral inhibitor of the C5a receptor (C5aR), in ...
All Penny Stocks (English) on MSN
Biotech surges as big money backs high-stakes kidney disease push
The immune system has become one of biotech's most important battlegrounds as drug developers race to target inflammatory ...
Kate Markey, MBBS, PhD, has discovered a link between the intestinal microbiome and developing chronic graft-versus-host ...
Thousands of times per year, a family’s moment of joy turns to unexpected grief. A seemingly healthy infant stops smiling or ...
An unprecedented outbreak of hantavirus has rocked a luxury cruise ship off the coast of West Africa, triggering a tsunami of ...
The biggest of the aircraft planned for the Marines’ arsenal of unmanned flying logistics trucks is expected to be put ...
Nausea. Severe abdominal pain. Compulsive bathing. These are some of the hallmarks of cannabinoid hyperemesis syndrome, a medical condition that’s on the rise. ER visits linked to cannabinoid ...
While tics have been considered to result from an aberrant function of the brain's motor cortex, a Kobe University mouse study has now discovered a connection to the brain's emotional functions. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results